Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Antifibrinolytic
Introduction
Antifibrinolytics, such as aminocaproic acid (ε-aminocaproic acid) and tranexamic acid are used as inhibitors of fibrinolysis, which act by blocking the lysine-binding site on plasmin.
Tranexamic acid may reduce bleeding after orthopedic surgery[1]. Tranexamic acid may better than aminocaproic acid for reducing estimated blood loss in orthopedic surgery[2].
Tranexamic acid may reduce bleeding after trauma[3].
They are used in menorrhagia and bleeding tendency due to various causes.
References
References
- ↑ Sun Y, Jiang C, Li Q (2017). “A systematic review and meta-analysis comparing combined intravenous and topical tranexamic acid with intravenous administration alone in THA”. PLoS One. 12 (10): e0186174. doi:10.1371/journal.pone.0186174. PMC 5634626. PMID 29016673.
- ↑ Boese CK, Centeno L, Walters RW (2017). “Blood Conservation Using Tranexamic Acid Is Not Superior to Epsilon-Aminocaproic Acid After Total Knee Arthroplasty”. J Bone Joint Surg Am. 99 (19): 1621–1628. doi:10.2106/JBJS.16.00738. PMID 28976426.
- ↑ Ker K, Roberts I, Shakur H, Coats TJ (2015). “Antifibrinolytic drugs for acute traumatic injury”. Cochrane Database Syst Rev (5): CD004896. doi:10.1002/14651858.CD004896.pub4. PMID 25956410.
External links
External links
- Antifibrinolytics at the US National Library of Medicine Medical Subject Headings (MeSH)
- Template:MeshPharmaList
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]